Weight loss drug tested as potential new tool to curb alcohol use
NCT ID NCT05891587
Summary
This study tested whether a medication called semaglutide, often used for weight loss and diabetes, could safely help people with alcohol use disorder drink less. 80 participants were randomly assigned to receive either weekly injections of semaglutide or a placebo (inactive shot) for 12 weeks. Researchers measured changes in drinking habits, safety, and even used brain scans to understand how the medication might work.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
OSU Biomedical Imaging Center
Tulsa, Oklahoma, 74136, United States
Conditions
Explore the condition pages connected to this study.